Lyra Therapeutics (LYRA) Shares Outstanding (Diluted) (2021 - 2025)
Lyra Therapeutics' Shares Outstanding (Diluted) was 1.55 million in Q4 2025, up 19.3% from 1.3 million a year earlier but down 12.1% from the prior quarter.
Powered by 
Analysis
Lyra Therapeutics (LYRA) Shares Outstanding (Diluted) (2021 - 2025) Analysis & Trends
From Q1 2021 onward, Lyra Therapeutics has reported Shares Outstanding (Diluted) for 20 quarters.
- Shares Outstanding (Diluted) has now increased for four consecutive years, with a four-year compound annual growth rate of 56.4% (FY2021 to FY2025).
- In earlier years, Shares Outstanding (Diluted) was 1.3 million in FY2024 (+30.7%), 996,086 in FY2023 (+64.7%), 604,714 in FY2022 (+132.8%) and 259,722 in FY2021.
- Quarterly Shares Outstanding (Diluted) has moved between 258,911 (Q1 2021) and 1.77 million (Q3 2025) over five years.
- Compared with a year earlier, Shares Outstanding (Diluted) has increased for 16 straight quarters, with growth averaging 28.7% over the last eight quarters.
- Over the past five years, the year-over-year growth in Shares Outstanding (Diluted) ranged from 0.5% (Q1 2022) to 183.2% (Q3 2022).
- Per Business Quant data, LYRA's Shares Outstanding (Diluted) in the three quarters before Q4 2025 was 1.77 million (Q3 2025), 1.35 million (Q2 2025) and 1.32 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.44 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 1.96 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.56 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 544.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 255.20 Mn |
| 10 | Lyra Therapeutics | 354,976.41 | 354,976.41 | - | 1.55 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 1.55 Mn |
| Sep 30, 2025 | 1.77 Mn |
| Jun 30, 2025 | 1.35 Mn |
| Mar 31, 2025 | 1.32 Mn |
| Dec 31, 2024 | 1.30 Mn |
| Sep 30, 2024 | 1.31 Mn |
| Jun 30, 2024 | 1.31 Mn |
| Mar 31, 2024 | 1.28 Mn |
| Dec 31, 2023 | 996,086.00 |
| Sep 30, 2023 | 1.14 Mn |
| Jun 30, 2023 | 873,528.00 |
| Mar 31, 2023 | 736,655.00 |
| Dec 31, 2022 | 604,714.00 |
| Sep 30, 2022 | 736,527.00 |
| Jun 30, 2022 | 678,929.00 |
| Mar 31, 2022 | 260,176.00 |
| Dec 31, 2021 | 259,722.00 |
| Sep 30, 2021 | 260,030.00 |
| Jun 30, 2021 | 259,837.00 |
| Mar 31, 2021 | 258,911.00 |
API Access
Lyra Therapeutics Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=LYRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "LYRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=LYRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();